Stockscreener 앱 받기
2.38
10.19%
-0.27
시간 외 거래:
2.39
0.01
+0.42%
전일 마감가:
$2.65
열려 있는:
$2.66
하루 거래량:
2.46M
Relative Volume:
1.12
시가총액:
$126.48M
수익:
$832.00K
순이익/손실:
$-135.12M
주가수익비율:
-0.3908
EPS:
-6.09
순현금흐름:
$-124.69M
1주 성능:
-14.70%
1개월 성능:
+59.73%
6개월 성능:
+16.10%
1년 성능:
-64.10%
1일 변동 폭
$2.38
$2.6689
1주일 범위
$2.38
$2.9789
52주 변동 폭
$1.30
$7.00
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
명칭
Inovio Pharmaceuticals Inc
전화
(858) 410-3134
주소
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
INO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.38 | 140.30M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Piper Sandler | Overweight |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2024-01-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-11-09 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2022-11-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-19 | 재개 | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-12-29 | 재개 | Jefferies | Hold |
| 2021-09-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-06-24 | 개시 | Jefferies | Hold |
| 2021-03-23 | 개시 | BofA Securities | Neutral |
| 2021-02-12 | 개시 | Oppenheimer | Outperform |
| 2020-11-17 | 다운그레이드 | ROTH Capital | Neutral → Sell |
| 2020-11-10 | 업그레이드 | ROTH Capital | Sell → Neutral |
| 2020-09-28 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-07-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-07-01 | 다운그레이드 | ROTH Capital | Neutral → Sell |
| 2020-06-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-21 | 개시 | The Benchmark Company | Buy |
| 2020-04-30 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-03-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | 개시 | ROTH Capital | Buy |
| 2018-02-15 | 재확인 | Maxim Group | Buy |
| 2017-10-18 | 개시 | RBC Capital Mkts | Outperform |
| 2017-09-06 | 개시 | Citigroup | Buy |
| 2017-06-08 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | 재확인 | Maxim Group | Buy |
| 2017-03-16 | 업그레이드 | Maxim Group | Hold → Buy |
| 2017-03-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
모두보기
Inovio Pharmaceuticals Inc 주식(INO)의 최신 뉴스
Nuveen LLC Acquires Shares of 103,297 Inovio Pharmaceuticals, Inc. $INO - MarketBeat
Inovio Pharmaceuticals (NASDAQ:INO) Downgraded to "Hold" Rating by Zacks Research - MarketBeat
Recurrent Respiratory Papillomatosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Precigen, Inovio Pharma - Barchart.com
Inovio Pharmaceuticals Inc. At Decision Level — Rebound or Resistance2025 Breakouts & Breakdowns & Daily Momentum Trading Reports - beatles.ru
Published on: 2025-09-06 13:36:33 - Newser
What is Inovio Pharmaceuticals Inc.’s market position2025 Technical Overview & Weekly Consistent Profit Watchlists - خودرو بانک
Ranking Inovio Pharmaceuticals Inc. among high performing stocks via tools - Newser
Does Inovio Pharmaceuticals Inc. have pricing powerQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - خودرو بانک
Does Inovio Pharmaceuticals Inc. meet Warren Buffett’s criteriaPrice Action & Daily Volume Surge Signals - خودرو بانک
Can Inovio Pharmaceuticals Inc. maintain sales growthEarnings Overview Summary & Weekly High Potential Alerts - خودرو بانک
Visual trend scoring systems applied to Inovio Pharmaceuticals Inc.Market Risk Summary & Verified Swing Trading Watchlist - Newser
Inovio Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Rallies & High Yield Stock Recommendations - Newser
Will a bounce in Inovio Pharmaceuticals Inc. offer an exit2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Inovio at H.C. Wainwright: Progress on DNA Medicine By Investing.com - Investing.com Canada
Inovio Pharmaceuticals shares fall 1.82% intraday after presenting at H.C. Wainwright conference. - AInvest
Is Inovio Pharmaceuticals Inc. benefiting from innovation trendsJuly 2025 Chart Watch & Fast Gaining Stock Reports - خودرو بانک
Inovio at H.C. Wainwright: Progress on DNA Medicine - Investing.com
Historical volatility pattern of Inovio Pharmaceuticals Inc. visualized2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
Custom watchlist performance reports with Inovio Pharmaceuticals Inc.July 2025 Macro Moves & Weekly High Return Stock Forecasts - Newser
Will Inovio Pharmaceuticals Inc. stock recover after recent drop2025 Historical Comparison & Advanced Swing Trade Entry Plans - Newser
How to build a dashboard for Inovio Pharmaceuticals Inc. stockGap Up & Free Expert Approved Momentum Trade Ideas - Newser
Pattern recognition hints at Inovio Pharmaceuticals Inc. upsidePortfolio Update Report & Verified Momentum Stock Alerts - Newser
How institutional ownership impacts Inovio Pharmaceuticals Inc. stockLong Setup & Technical Pattern Alert System - Newser
Combining price and volume data for Inovio Pharmaceuticals Inc.Portfolio Gains Report & Long Hold Capital Preservation Plans - Newser
Exit strategy if you’re trapped in Inovio Pharmaceuticals Inc.2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
Is Inovio Pharmaceuticals Inc. a candidate for recovery playMarket Sentiment Report & Growth Focused Stock Reports - Newser
Inovio Pharmaceuticals Inc. stock prediction for this week2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - Newser
Detecting support and resistance levels for Inovio Pharmaceuticals Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser
What MACD and RSI say about Inovio Pharmaceuticals Inc.July 2025 Catalysts & Risk Controlled Stock Pick Alerts - Newser
Using data filters to optimize entry into Inovio Pharmaceuticals Inc.2025 Analyst Calls & Capital Protection Trading Alerts - Newser
What’s the recovery path for long term holders of Inovio Pharmaceuticals Inc.Weekly Volume Report & Verified Stock Trade Ideas - Newser
Is Inovio Pharmaceuticals Inc. stock poised for growthMarket Trend Review & Smart Allocation Stock Reports - Newser
How to forecast Inovio Pharmaceuticals Inc. trends using time seriesEarnings Overview Summary & AI Powered Market Trend Analysis - Newser
Inovio Pharmaceuticals Inc. Could See a Relief Rally From SupportEarnings Overview Summary & Fast Gaining Stock Strategy Reports - beatles.ru
Inovio Pharmaceuticals Inc. stock daily chart insightsPrice Action & Stock Market Timing Techniques - Newser
Gainers Report: Can Inovio Pharmaceuticals Inc. be recession proofJuly 2025 Fed Impact & Reliable Volume Spike Trade Alerts - خودرو بانک
Sector ETF performance correlation with Inovio Pharmaceuticals Inc.Portfolio Gains Report & Daily Technical Forecast Reports - Newser
Reversal indicators forming on Inovio Pharmaceuticals Inc. stock2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Can Inovio Pharmaceuticals Inc. outperform in the next rallyJuly 2025 Big Picture & Free Safe Entry Trade Signal Reports - خودرو بانک
Comparing Inovio Pharmaceuticals Inc. in custom built stock radarsJuly 2025 News Drivers & Proven Capital Preservation Tips - Newser
Advanced analytics toolkit walkthrough for Inovio Pharmaceuticals Inc.July 2025 Macro Moves & Verified Entry Point Signals - Newser
Published on: 2025-09-02 16:02:26 - Newser
Will Inovio Pharmaceuticals Inc. stock recover after earningsJuly 2025 Recap & Verified Momentum Stock Watchlist - خودرو بانک
Inovio Pharmaceuticals Inc (INO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.10%
자본화:
|
볼륨(24시간):